A variety of nanoparticles are under development for medicine, energy, food and cosmetics. Both organic and inorganic nanoparticles are playing an increased role in industrial and medical applications. However, little is known about their distribution and effects on the human body, and as a result concerns exist about potential health risks and safety problems. The long-term aim of this research is to quantify the distribution characteristics of nanoparticles and explore how the physicochemical properties of nanoparticles influence their distribution. A physiologically based pharmacokinetic (PBPK) model was successfully developed to describe the pharmacokinetics and biodistribution of nanoparticles in various tissues and blood of the bod...
Computational modelling has gained attention for evaluating nanoparticle-based drug delivery systems...
A promise of cancer nanomedicine is the “targeted” delivery of therapeutic agents to tumors by the r...
Data suitable for assembling a physiologically-based pharmacokinetic (PBPK) model for nanoparticles ...
[[abstract]]The worldwide commerce involving nanoparticles will soon reach $1 trillion and already w...
Prasad DhurjatiNanomedicine refers to the application of nanotechnology to medicine and includes suc...
[[abstract]]The worldwide commerce involving nanoparticles will soon reach $1 trillion and already w...
The prospects of nanoparticle-based drug delivery and imaging have been hindered by insufficient und...
To predict the toxicity of nanoparticles (1-100 nm), it is crucial to understand their biokinetics i...
BACKGROUND: Physiologically based pharmacokinetic (PBPK) modeling is an important tool in predicting...
© 2016 American Chemical Society. A physiologically based pharmacokinetic model was developed for ac...
The use of nanobiomaterials (NBMs) is becoming increasingly popular in the field of medicine. To imp...
The use of nanoparticles (NPs) can support an enhancement of drug distribution, resulting in increas...
The same novel properties of engineered nanoparticles that make them attractive may also present uni...
Blood kinetics and tissue distribution of 20, 80 and 110 nm silver nanoparticles were investigated i...
A physiologically based pharmacokinetic model was developed for accurately characterizing and predic...
Computational modelling has gained attention for evaluating nanoparticle-based drug delivery systems...
A promise of cancer nanomedicine is the “targeted” delivery of therapeutic agents to tumors by the r...
Data suitable for assembling a physiologically-based pharmacokinetic (PBPK) model for nanoparticles ...
[[abstract]]The worldwide commerce involving nanoparticles will soon reach $1 trillion and already w...
Prasad DhurjatiNanomedicine refers to the application of nanotechnology to medicine and includes suc...
[[abstract]]The worldwide commerce involving nanoparticles will soon reach $1 trillion and already w...
The prospects of nanoparticle-based drug delivery and imaging have been hindered by insufficient und...
To predict the toxicity of nanoparticles (1-100 nm), it is crucial to understand their biokinetics i...
BACKGROUND: Physiologically based pharmacokinetic (PBPK) modeling is an important tool in predicting...
© 2016 American Chemical Society. A physiologically based pharmacokinetic model was developed for ac...
The use of nanobiomaterials (NBMs) is becoming increasingly popular in the field of medicine. To imp...
The use of nanoparticles (NPs) can support an enhancement of drug distribution, resulting in increas...
The same novel properties of engineered nanoparticles that make them attractive may also present uni...
Blood kinetics and tissue distribution of 20, 80 and 110 nm silver nanoparticles were investigated i...
A physiologically based pharmacokinetic model was developed for accurately characterizing and predic...
Computational modelling has gained attention for evaluating nanoparticle-based drug delivery systems...
A promise of cancer nanomedicine is the “targeted” delivery of therapeutic agents to tumors by the r...
Data suitable for assembling a physiologically-based pharmacokinetic (PBPK) model for nanoparticles ...